Integra LifeSciences (IART) Numbers Lifted at Jefferies Post Q3
Jefferies reiterated a Buy rating and raised its price target on Integra LifeSciences (NASDAQ: IART) from $46 to $54 following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
